- Home
- CERS vs SMTI Comparison
CERS vs SMTI Comparison
Compare CERS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- SMTI
- Stock Information
- Founded
- CERS 1991
- SMTI 1982
- Country
- CERS United States
- SMTI United States
- Employees
- CERS N/A
- SMTI N/A
- Industry
- CERS EDP Services
- SMTI Medical/Dental Instruments
- Sector
- CERS Technology
- SMTI Health Care
- Exchange
- CERS Nasdaq
- SMTI Nasdaq
- Market Cap
- CERS 324.3M
- SMTI 288.2M
- IPO Year
- CERS 1997
- SMTI N/A
- Fundamental
- Price
- CERS $1.58
- SMTI $33.01
- Analyst Decision
- CERS Buy
- SMTI Buy
- Analyst Count
- CERS 3
- SMTI 1
- Target Price
- CERS $3.17
- SMTI $44.00
- AVG Volume (30 Days)
- CERS 1.2M
- SMTI 36.4K
- Earning Date
- CERS 10-30-2024
- SMTI 11-12-2024
- Dividend Yield
- CERS N/A
- SMTI N/A
- EPS Growth
- CERS N/A
- SMTI N/A
- EPS
- CERS N/A
- SMTI N/A
- Revenue
- CERS $176,229,000.00
- SMTI $78,056,873.00
- Revenue This Year
- CERS $26.47
- SMTI $29.95
- Revenue Next Year
- CERS $11.48
- SMTI $19.68
- P/E Ratio
- CERS N/A
- SMTI N/A
- Revenue Growth
- CERS 14.71
- SMTI 24.66
- 52 Week Low
- CERS $1.38
- SMTI $26.00
- 52 Week High
- CERS $2.59
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- CERS 38.88
- SMTI 34.95
- Support Level
- CERS $1.53
- SMTI $31.13
- Resistance Level
- CERS $1.83
- SMTI $34.22
- Average True Range (ATR)
- CERS 0.11
- SMTI 1.80
- MACD
- CERS -0.03
- SMTI -0.63
- Stochastic Oscillator
- CERS 13.89
- SMTI 12.98
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.